Insights

Hematology focus Oncopeptides specializes in therapies for difficult-to-treat hematological diseases, presenting a clear target for partnerships or co-development in cancer and blood disorder markets.

U.S. presence With a U.S. headquarters in Waltham and a footprint in Los Altos, there are established regional access points for US market outreach, clinical collaborations, and payer conversations.

Early-stage revenue Current revenue is under one million, indicating a potential opportunity for early-commercial or strategic investments, high-value US market entry strategies, and tiered partnerships to accelerate growth.

Tech readiness Existing tech stack components like Cloudflare, WordPress, Shopify, and JSON-LD suggest a foundation for digital marketing, e-commerce enablement for patient access programs, and scalable outbound campaigns.

Talent and scale Medium-sized team (201-500 employees) across key biotech hubs implies potential for collaboration in clinical operations, regulatory support, and commercial launch activities, especially in collaboration with larger pharma partners.

Similar companies to Oncopeptides, Inc. (U.S.)

Oncopeptides, Inc. (U.S.) Tech Stack

Oncopeptides, Inc. (U.S.) uses 8 technology products and services including Open Graph, WordPress, Cookiebot, and more. Explore Oncopeptides, Inc. (U.S.)'s tech stack below.

  • Open Graph
    Content Management System
  • Content Management System
  • Cookie Compliance
  • E-commerce
  • JSON-LD
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • PWA
    Miscellaneous
  • Platform As A Service

Oncopeptides, Inc. (U.S.)'s Email Address Formats

Oncopeptides, Inc. (U.S.) uses at least 6 email formats:
Oncopeptides, Inc. (U.S.) Email FormatsExamplePercentage
First.Last@oncopeptides.comJohn.Doe@oncopeptides.com
91%
FirstLast@oncopeptides.comJohnDoe@oncopeptides.com
5%
First.Middle.Last@oncopeptides.comJohn.Michael.Doe@oncopeptides.com
3%
LastF@oncopeptides.comDoeJ@oncopeptides.com
1%
First-Last@oncopeptides-us.comJohn-Doe@oncopeptides-us.com
67%
LastF@oncopeptides-us.comDoeJ@oncopeptides-us.com
33%

Frequently Asked Questions

What is Oncopeptides, Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s official website is oncopeptides-us.com and has social profiles on LinkedIn.

How much revenue does Oncopeptides, Inc. (U.S.) generate?

Minus sign iconPlus sign icon
As of August 2026, Oncopeptides, Inc. (U.S.)'s annual revenue is estimated to be <$1M.

What is Oncopeptides, Inc. (U.S.)'s NAICS code?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Oncopeptides, Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of August 2026, Oncopeptides, Inc. (U.S.) has approximately 201 employees across 1 continents, including North America. Key team members include Head Of Research: F. L., Head Of Us Human Resources: M. F. and Executive Director, Medical Affairs: E. M. Explore Oncopeptides, Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Oncopeptides, Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) operates in the Pharmaceuticals industry.

What technology does Oncopeptides, Inc. (U.S.) use?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s tech stack includes Open Graph, WordPress, Cookiebot, Shopify, JSON-LD, jQuery, PWA and Microsoft Azure.

What is Oncopeptides, Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s email format typically follows the pattern of First.Last@oncopeptides.com. Find more Oncopeptides, Inc. (U.S.) email formats with LeadIQ.

When was Oncopeptides, Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) was founded in 2000.
Oncopeptides, Inc. (U.S.) logo

Oncopeptides, Inc. (U.S.)

PharmaceuticalsMassachusetts, United States201-500 Employees

Oncopeptides, Inc. operates within the pharmaceutical manufacturing sector, focusing on developing therapies for difficult-to-treat hematological diseases. The company aims to provide treatment options driven by scientific research and innovation, with a mission that centers on offering new possibilities to patients, caregivers, and healthcare providers dealing with cancer. Its U.S. presence is headquartered in Waltham, Massachusetts, with additional footprint in California, and its global headquarters are in Stockholm, Sweden, reflecting a bi-national orientation and a broader development platform.

Positioned in the specialty biopharma space, Oncopeptides concentrates on addressing unmet clinical needs in hematology. The organization serves a medical and professional audience that seeks advanced treatment options for challenging blood cancers, operating from multiple U.S. locations to support its activities in a major biotechnology corridor. The information indicates a formal corporate footprint in the Boston-area region to facilitate its U.S. operations and research collaborations.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2000
Employees
201-500

Section iconFunding & Financials

  • <$1M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.